Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

G9071 is a valid 2023 HCPCS Code that could be used to indicate Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) for reimbursement purposes.

G9071 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2007.

Short description for G9071 HCPCS code:

Onc dx brst stg1-2b hr,nopro